USA-based Climb Bio said yesterday it has entered into an exclusive license agreement with Beijing Mabworks Biotech for ...

Alentis Therapeutics ("Alentis"), a clinical-stage biotechnology company developing treatments for Claudin-1 positive (CLDN1+) tumors and organ fibrosis, announced positive topline results from two ...

Eliem Therapeutics is continuing its transformation into an immune-mediated disease company by paying $9 million to ...

Transaction Expands Climb Bio’s Pipeline of B-cell Targeted Therapeutics to Address Immune-mediated Diseases New Program is a Highly Potent, Fc-engineered anti-APRIL Monoclonal Antibody Specifically ...

IgA nephropathy (IgAN) is a prevalent form of primary glomerulonephritis characterized by the deposition of IgA in the glomerular mesangium, leading to a spectrum of histopathological lesions and a ...

Local actor-DJ Mark Lee’s younger daughter Calynn may have to ring in the new year in hospital, but she does not want her ...

Mark Lee's younger daughter Calynn is in hospital for a checkup and may have to stay there over New Year's Eve. Earlier today ...

Calynn was diagnosed in 2018 with glomerulonephritis, a rare condition affecting the kidneys, but her condition has improved ...

Calynn was diagnosed in 2018 with glomerulonephritis, a rare condition affecting the kidneys. Read more at straitstimes.com.

Iptacopan hydrochloride is under clinical development by Novartis and currently in Phase II for Microscopic Polyangiitis (MPA).

小女儿李紫菡2018年被查出免疫系统失调导致肾脏受损，患上肾小球性肾炎（Glomerulonephritis），当时她只有五岁。不过近年来病情已经好转，这次入院主要是为了全面了解健康情况，确保一切都在正常范围内。

Nephrologists have decried the rise in cases of  kidney diseases among young adults in the country, disclosing that the ...